Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Board Committee changes

22 Nov 2023 07:00

RNS Number : 2062U
Johnson Matthey PLC
22 November 2023
 

 

22nd November 2023

 

Johnson Matthey Plc

(the Company)

Board Committee changes

 

The Company announces the following changes to the composition of its Board Committees in respect of non-executive directors, effective from 2nd January 2024. These changes align with the Company's overall approach to simplifying the business and enhancing efficiency to deliver its strategic priorities:

 

· Audit Committee: Xiaozhi Liu and Chris Mottershead will step down as members.

 

· Remuneration Committee: Barbara Jeremiah and Rita Forst will step down as members.

 

· Societal Value Committee: Patrick Thomas, Xiaozhi Liu, Chris Mottershead and Doug Webb will step down as members.

 

As previously announced, Chris Mottershead will step down from the Board on 26th January 2024.

 

The Board and Committee membership as at 2nd January 2024 is set out below:

 

Board membership

 

Patrick Thomas

Liam Condon

Stephen Oxley

Barbara Jeremiah

Rita Forst

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Chair

Chief Executive Officer

Chief Financial Officer

Senior Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Independent Non-Executive Director

Board Committee

 

Committee Chair

Members

Audit Committee

 

Doug Webb*

 

Rita Forst

Jane Griffiths

Barbara Jeremiah

John O'Higgins

 

Remuneration Committee

John O'Higgins

Jane Griffiths

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Nomination Committee

 

Patrick Thomas

 

Rita Forst

Barbara Jeremiah

Jane Griffiths

John O'Higgins

Xiaozhi Liu

Chris Mottershead

Doug Webb

 

Societal Value Committee

Jane Griffiths

 

Liam Condon

Barbara Jeremiah

Rita Forst

John O'Higgins

Stephen Oxley

 

 

* Audit Committee financial expert

 

 

This announcement is made in accordance with Listing Rule 9.6.11.

 

 

ENDS

 

Notes

Biographies of each Board member and the Terms of Reference of each Board Committee are available at www.matthey.com

 

Enquiries: 

 

Simon Price

General Counsel and Company Secretary

+44 20 7269 8052

Martin Dunwoodie

Director of Investor Relations

+44 20 7269 8241

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOANKDBBDBDBADB
Date   Source Headline
3rd Aug 20173:49 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:46 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:41 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:37 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:30 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:20 pmRNSDirector/PDMR Shareholding
3rd Aug 20173:16 pmRNSDirector/PDMR Shareholding
1st Aug 201711:33 amRNSDirector/PDMR Shareholding
31st Jul 20174:21 pmRNSDirector/PDMR Shareholding
28th Jul 20172:42 pmRNSResult of AGM
28th Jul 20177:00 amRNSAGM Statement
26th Jul 201710:02 amRNSDirectorate Changes
21st Jul 201711:02 amRNSDirector/PDMR Shareholding
22nd Jun 20172:58 pmRNSDirector/PDMR Shareholding
20th Jun 201711:43 amRNSAnnual Financial Report
1st Jun 20174:19 pmRNSDirectorate Change
1st Jun 20177:00 amRNSFinal Results
19th May 20175:00 pmRNSHolding(s) in Company
18th May 20175:24 pmRNSDirector/PDMR Shareholding
18th May 20175:16 pmRNSDirector/PDMR Shareholding
3rd May 201711:04 amRNSDirector/PDMR Shareholding
27th Apr 20174:40 pmRNSHolding(s) in Company
21st Apr 20171:54 pmRNSDirector/PDMR Shareholding
20th Apr 20174:00 pmRNSOrganisation Changes
27th Mar 20175:56 pmRNSHolding(s) in Company
16th Mar 20172:28 pmRNSDirector/PDMR Shareholding
20th Feb 20174:04 pmRNSDirector/PDMR Shareholding
16th Feb 20173:14 pmRNSDirector/PDMR Shareholding
10th Feb 20172:54 pmRNSDirector/PDMR Shareholding
10th Feb 20171:19 pmRNSDirector/PDMR Shareholding
10th Feb 20171:12 pmRNSDirector/PDMR Shareholding
10th Feb 20171:07 pmRNSDirector/PDMR Shareholding
6th Feb 20172:55 pmRNSDirector/PDMR Shareholding
2nd Feb 20177:00 amRNSTrading Statement
19th Jan 20173:09 pmRNSDirector/PDMR Shareholding
22nd Dec 201612:21 pmRNSDirector/PDMR Shareholding
16th Dec 201611:39 amPRNHolding(s) in Company
9th Dec 20169:56 amRNSDirector/PDMR Shareholding
1st Dec 20161:39 pmPRNBlocklisting - Interim Review
25th Nov 20168:59 amRNSDirector/PDMR Shareholding
18th Nov 201610:14 amRNSDirector/PDMR Shareholding
17th Nov 20167:00 amRNSHalf-year Report
20th Oct 20161:45 pmRNSDirector/PDMR Shareholding
23rd Sep 20169:14 amRNSDirector/PDMR Shareholding
22nd Sep 201611:45 amPRNHolding(s) in Company
18th Aug 20163:49 pmRNSDirector/PDMR Shareholding
16th Aug 20163:44 pmRNSDirector/PDMR Shareholding
16th Aug 20163:41 pmRNSDirector/PDMR Shareholding
16th Aug 20163:36 pmRNSDirector/PDMR Shareholding
5th Aug 201610:35 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.